Cargando…

Cell Therapies for Parkinson's Disease

Detalles Bibliográficos
Autor principal: Irion, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440559/
https://www.ncbi.nlm.nih.gov/pubmed/30771274
http://dx.doi.org/10.1111/cts.12612
_version_ 1783407408985407488
author Irion, Stefan
author_facet Irion, Stefan
author_sort Irion, Stefan
collection PubMed
description
format Online
Article
Text
id pubmed-6440559
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64405592019-04-11 Cell Therapies for Parkinson's Disease Irion, Stefan Clin Transl Sci Perspectives John Wiley and Sons Inc. 2019-02-16 2019-03 /pmc/articles/PMC6440559/ /pubmed/30771274 http://dx.doi.org/10.1111/cts.12612 Text en © 2019 BlueRock Therapeutics. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Perspectives
Irion, Stefan
Cell Therapies for Parkinson's Disease
title Cell Therapies for Parkinson's Disease
title_full Cell Therapies for Parkinson's Disease
title_fullStr Cell Therapies for Parkinson's Disease
title_full_unstemmed Cell Therapies for Parkinson's Disease
title_short Cell Therapies for Parkinson's Disease
title_sort cell therapies for parkinson's disease
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440559/
https://www.ncbi.nlm.nih.gov/pubmed/30771274
http://dx.doi.org/10.1111/cts.12612
work_keys_str_mv AT irionstefan celltherapiesforparkinsonsdisease